Titel
Accueil
Navigation principale
Contenu
Recherche
Aide
Fonte
Standard
Gras
Identifiant
Interrompre la session?
Une session sous le nom de
InternetUser
est en cours.
Souhaitez-vous vraiment vous déconnecter?
Interrompre la session?
Une session sous le nom de
InternetUser
est en cours.
Souhaitez-vous vraiment vous déconnecter?
Accueil
Plus de données
Partenaires
Aide
Mentions légales
D
F
E
La recherche est en cours.
Interrompre la recherche
Recherche de projets
Projet actuel
Projets récents
Graphiques
Identifiant
Titel
Titel
Unité de recherche
COST
Numéro de projet
C09.0042
Titre du projet
Cysteine Proteinases and Cell Death cascade in Leishmania parasites
Titre du projet anglais
Cysteine Proteinases and Cell Death cascade in Leishmania parasites
Données de base
Textes
Participants
Titel
Textes relatifs à ce projet
Allemand
Français
Italien
Anglais
Mots-clé
-
-
-
Programme de recherche
-
-
-
Description succincte
-
-
-
Partenaires et organisations internationales
-
-
-
Résumé des résultats (Abstract)
-
-
-
Références bases de données
-
-
-
Textes saisis
Catégorie
Texte
Mots-clé
(Anglais)
cell death; metacaspase; synthetic peptide; anti leishmanial drugs
Programme de recherche
(Anglais)
COST-Action BM0802 - Life or death of protozoan parasites
Description succincte
(Anglais)
In protozoan parasites, molecular mechanisms implicated in the cell death (CD) pathway are thus far poorly characterized. In the parasite Leishmania, anti-leishmania drugs, nitric oxide (NO) and hydrogen peroxide (H2O2) have been shown to induce defined cell death (CD) markers. These treatments induce CD together with processing of the metacaspase and the release of a lysosomal cathepsin B-like enzyme as executioner proteases in the CD cascade. In this proposal, we intend to characterize events in the CD cascade of Leishmania parasites with the aim to validate the relevance of the cathepsin B-like enzyme in relation to Leishmania metacaspase, to identify its substrates in physiological and stress situations and to determine the relationship between the CD cascade and the action of anti-leishmania drugs.
Partenaires et organisations internationales
(Anglais)
BE, CH, DE, DK, ES, FR, GR, IL, IT, NL, PT, UK
Résumé des résultats (Abstract)
(Anglais)
It is now admitted that single celled protozoan parasites undergo cell death in a regulated manner. Nevertheless, the molecular pathway underneath remains to be established. As trypanosomes do not encode caspases, the key mediators of programmed cell death in higher eukaryotes, we investigated the metacaspase protein (LmjMCA), which has been described as a caspase homologue that is mainly restricted to lower eukaryotes and plants. We showed that, in stress conditions, LmjMCA precursor forms were extensively processed into soluble forms containing the catalytic domain and this domain was sufficient to enhance sensitivity of parasites to hydrogen peroxide by impairing the mitochondrion function. We then tested different lengths of LmjMCA catalytic domain and found that the overexpression of the polypeptide corresponding to amino acids 136-218 was sufficient to sensitize L. major mitochondria to oxidative stress. These findings were used to synthesize an 83aa long peptide corresponding to the minimal metacaspase catalytic domain. We showed that the peptide was catalytically active in vitro and that it was able to participate in the cell death pathway in vivo. We also showed that our active peptide was able to enter infected cells and could eliminate parasites present in macrophages or in parasite induced lesions. Therefore, based on a peptide implicated in the cell death of parasites, we could conclude that metacaspase could be a valuable tool to prevent the formation of lesions or to reduce the severity of the disease. Potentially, this approach could be used for other pathogens expressing metacaspase such as Plasmodium or pathogenic fungi.
Références bases de données
(Anglais)
Swiss Database: COST-DB of the State Secretariat for Education and Research Hallwylstrasse 4 CH-3003 Berne, Switzerland Tel. +41 31 322 74 82 Swiss Project-Number: C09.0042
SEFRI
- Einsteinstrasse 2 - 3003 Berne -
Mentions légales